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amplification primers. During RE-PCR the specific primer blocks amplification of the full length 23 redundant gene. Using this method we managed to clone a number of cry8 or cry9 toxin genes 24 from a pool of Bacillus thuringiensis genomic DNA while excluding amplicons for cry9Da, 25 cry9Ea and cry9Eb. The method proved very efficient at increasing the number of rare genes in 26 the resulting library. One such rare, and novel, cry8-like gene was expressed and the encoded 27 toxin was shown to be toxic to Anomola corpulenta. 28
Importance 29
Protein toxins from the bacterium Bacillus thuringiensis are being increasingly used as 30 biopesticides against a wide range of insect pests, yet the search for new or improved toxins is 31 becoming more difficult as traditional methods for gene discovery routinely isolate previously 32 identified clones. This paper describes an approach that we have developed to increase the success 33 rate for novel toxin gene identification through reducing or eliminating the cloning of previously 34 characterized genes. 35
Introduction 36
As a result of the proteinaceous insecticidal toxins produced by Bacillus thuringiensis (Bt) 37 this bacterium has become a commercially successful biopesticide [1] . Products based on Bt 38 include formulations of the bacterium itself or the toxin expressed in an alternative host -in 39 particular genetically modified crops [2] . Despite the increasing use of these products there 40 remains a need to discover new toxins with desirable properties -such properties include an 41 increased activity against a given target, activity against a new target pest or the ability to control a 42 pest that has developed resistance to an existing toxin. A number of different approaches can be 43 used to identify novel toxins, the traditional one being to screen strains for a desired activity and 44 then isolate the active ingredient. In recent times molecular approaches have been increasingly 45 used including genome sequencing [3] and PCR techniques. The latter rely on there being 46 conserved regions present in toxin gene families as well as the more variable regions that give 47 toxins their individual characteristics [4] . Improved PCR procedures have allowed the successful 48 cloning of Bt toxin genes from complex DNA mixtures prepared from pooled samples [5, 6] . A 49 problem with this sort of approach however is the high ratio of known or undesired toxin genes in 50 libraries made from these pooled samples which has made the discovery of new genes 51 increasingly difficult. 52 B. thuringiensis Cry8 and Cry9 proteins have significantly different insecticidal spectra 53 despite phylogenetic analyses indicating that they share high sequence similarity in domains I and 54 II [7, 8] . Cry8 proteins are toxic to Coleopteran insects while Cry9s have high activity to 55
Lepidopteran insects [9] [10] [11] [12] , both are valuable toxins for insect pest management. This paper 56 describes a procedure developed to analyse cry8 and cry9 genes in a DNA pool prepared from 57 4 2000 Bt strains and used to efficiently clone novel isolates. 58
Materials and methods 59
Bacterial strains, plasmids, and growth conditions 60 Bt stains were isolated from soil samples in China as described previously [6] . E. coli DH5α 61 was used for standard transformations, whilst E.coli SCS110 (RpsL [strr], thr, leu, endA, 62 lacY, galK, galT, ara, tonA, tsx, dam, dcm, upE44, [F0 traD36 proAB 63 lacIqZDM15]) was used to produce non-methylated plasmid DNA for transformation of HD73 -, a 64 crystal-negative mutant strain of Bt. 65
The cloning vector pEB was constructed by inserting the pETblue-2 expression region into 66 the StyI-BglII sites of pET-21b. Plasmid pSTK containing the cry3Aa promoter and STAB-SD 67 sequence was constructed by Wang et al. [13] and used to express cry genes in HD73 -.
68
E.coli was incubated at 37°C in LB medium (1% NaCl, 1% tryptone, and 0.5% yeast extract), 69
and Bt strains were grown at 30°C on LB agar (1% NaCl, 1% tryptone, 0.5% yeast extract and 70
1.3%-1.5% agar). To select antibiotic-resistant E.coli and Bt strains, ampicillin and kanamycin 71 were added to the culture medium at a final concentration of 100 μg/ml and 50 μg/ml respectively. 72
All of the cultures were incubated in a rotary shaker at 220 rpm. 73
Identification of cry8 and cry9 genes from pooled genomic DNA 74
Pooled genomic DNA was prepared from 2000 Bt strains as described by Li et al [6] and 75 used as the template for PCR. A pair of universal primers cry_F and cry_R (Table 1) were 76 designed based on an alignment of cry8 and cry9 holotype genes and were used to amplify the 77 toxin coding region of these genes. A 50 μl PCR mixture contained 100 ng template DNA, 25 μl 78 2×PrimeSTAR master mix (TaKaRa, Dalian, China), and 0.2 μmol -l of each primer. The reaction 79 consisted of an initial denaturation step of 94°C for 5 min, 30 cycles of 94°C for 1min; 54°C for 80 1min; 72°C for 2 min 20 s, and final extension step of 72°C for 10 min. The resulting PCR 81 product was purified using a DNA gel extraction kit (AXYGEN, Hangzhou, China) and ligated 82 into the Ecl136II site of the pEB vector. 83
The cry9 and cry8 genes in the pooled DNA were classified by PCR-RFLP analysis. Genes 84 were amplified from library clones using cry_F and cry_R, digested with Hinf I, and then profiled 85 by 2% agarose gel electrophoresis. Clones with different restriction length fragment 86 polymorphism (RFLP) profiles were selected for sequencing. 87
Redundant Exclusion PCR 88
Primers RE9Da_F and RE9Ea/b_F (Table 2) were designed to specifically hybridize to 89 cry9Da, and to cry9Ea/cry9Eb respectively. Test reactions were performed in 20 μL total volume 90 containing 10 ng of cry9Ea and cry9Eb or cry9Da-encoding plasmid DNA, 0.2 μmolL -l primer 91
RE9Da_F or RE9Ea/b_F, 0.2 μmol L -l of primer cry_F and/or cry_R, and 10 μl 2×PrimeSTAR 92 master mix. PCR consisted of an initial denaturation step of 94°C for 5 min, 30 cycles of 94°C 93 1min; 54°C 1min; 72°C, 2 min 20 s, and a final extension step of 72°C for10 min. 94
Expression of the cry8-like gene 95
To express the truncated cry8-like gene in Bt, a seamless assembly cloning method was used 96 to fuse the truncated gene to DNA encoding the Cry8Ea C-terminal coding region. The primers 97 designed to amplify these two sections, with appropriate overlaps, are listed in Table 3 . A 10 μL 98 reaction mix containing 20 ng pSTK plasmid (linearized with BamHI+SalI), 30 ng each of the 99 PCR products and 5 μL 2×Assembly Master Mix (Seamless Assembly Cloning kit, CloneSmarter, 100 USA） was incubated at 50°C for 10 min. After transformation of E. coli DH5α the resulting hybrid 101 (hycry8) was sequenced using an automated DNA sequencer (ABI-3730XL, USA). The 102 recombinant plasmid, isolated from E.coli, was used to transform SCS110 prior to introduction 103 into Bt strain HD73 -by electroporation. A single transformant was selected from LB plates 104 containing kanamycin (50 g/ml) and incubated until sporulation at 30°C. The spore-crystal 105 mixture was washed and re-suspended in sterile distilled water, and the suspension was examined 106 by microscopy and SDS-PAGE analysis according to Shu et al [14] . For proteolytic activation the 107 toxin crystals were solubilized in 50mM Na 2 CO 3 pH10 and then treated with chymotrypsin (10:1 108 w/w) in PBS and incubated at 37°C for 2 h. 109
Insect bioassay 110
The insecticidal activity of spore-crystal mix from the recombinant Bt strain was tested 111 against larvae of 15-day-old Anomala corpulenta, 5-day-old Holotrichia parallela, and 5-day-old 112
Holotrichia oblita. The bioassay diet for these scarab larvae was prepared as described by Yu et al 113 [15] . For initial screening, we used a concentration of 1.0×10 8 colony forming units (CFU) g −1
soil. 114
Further assays were performed with samples showing toxicity to any of the pests in order to 115 determine LC 50 values. Bioassays were repeated at least twice, and LC 50 values were calculated 116 using probit analysis. 117
118

Results
119
Identification of cry8 and cry9 genes from pooled genomic DNA 120 A library of 2.1 kb PCR products encoding the active portion of cry8/9 toxin genes ( Fig.1A  121 lane1), produced from the pooled genomic DNA using primers cry_F and cry_R, was created and 122 subjected to PCR-RFLP analysis. Two hundred clones were tested and four distinct profile types 123 were detected . Representatives of these were sequenced and this indicated that 124 the four profiles belonged to cry9Da (100% identity to cry9Da4, accession number: GQ249297.1), 125 cry9Ea (99% identity to cry9Ea9, accession number: JN651495.1), cry9Eb (99% identity to 126 cry9Eb2, accession number: GQ249298.1) and a new cry8-like (86% identity to cry8Ab1, 127 accession number: EU044830.1). Figure 2 (solid bars) shows the relative frequency of these four 128 profiles, 70% of the clones matched the cry9Ea profile while 5% matched cry8-like. 129
Redundant Exclusion primer PCR 130
To exclude known genes from the library we relied on the fact that the high fidelity 131 polymerase that we used in our PCR reactions (PrimeSTAR GXL) lacks a 5'-3' exonuclease 132 activity and so polymerization can be halted by the presence of a bound oligonucleotide. We 133 designed primers that would specifically, and tightly, bind to particular cry8/9 genes and thus 134 prevent amplification of the full PCR product by the primers. The primers RE9Da_F and 135 RE9Ea/b_F (Tables 2 and 4) were designed to hybridize to variable regions in domain II of 136 cry9Da and cry9Ea/9Eb respectively. A number of PCRs were run to test these primers. When the 137 two amplification primers and the two redundant exclusion primers were all included in a 138 multiplex PCR (Fig1A lane 2) two distinct bands are seen, the 2.1kb band represents the full 139 length products amplified by cry_F and cry_R while the approximately 750 bp band represents the 140 fragment of the gene amplified by RE9Da_F/RE9Ea/b_F and cry_R. The source of this 750 bp 141 band was confirmed in separate reactions involving just an RE primer and cry_R (Fig 1A lanes 3  142 and 4). To confirm that the RE primers could block amplification of the corresponding gene pairs 143 of reactions were performed using specific genes as templates. Figure 1A inhibited by the appropriate RE primer. 146
A new library was created from the 2.1kb PCR product produced using cry_F and cry_R 147 from pooled DNA but this time including the RE primers in the amplification reaction. A total of 148 200 clones were analyzed by PCR-RFLP and this time five different profiles were obtained 149 (Fig.1B lanes 3-7) . Two of these profiles (cry9Ea and cry8-like) were the same as previously 150 identified while the other three corresponded to cry8Fa (99% identity to cry8Fa2, accession 151 number HQ174208.1), cry8Ab-like (99% identity to cry8Ab1-like, accession number: JF521572.1) 152 and cry8Ea (99% identity to cry8Ea1, accession number: AY329081.1). Although the cry9Ea 153 profile was detected despite the presence of the corresponding RE primer its frequency had 154 dropped dramatically (Figure 2 open bars) . The cry9Da and cry9Eb profiles had successfully been 155 excluded. In contrast the frequency of the cry8-like profile rose significantly. 156
Expression of the novel cry8-like gene 157
The cry_F and cry_R primers were designed to amplify the active toxin portion of the cry8/9 158 genes but not the region encoding the C-terminal crystallization domain [4] . To express a complete 159 toxin we added this C-terminal region from a homologous gene, cry8Ea. Figure 3 shows the 160 sequence of the Cry8-like toxin and the resulting hybrid (hyCry8). The hybrid gene wassub-cloned into pSTK and introduced into HD73 -for expression. The hyCry8 protein expressed 162 well in this host (Fig.4C lane 2) and accumulated as spherical crystals (Fig.4B) .When the protoxin 163 was treated with chymotrypsin ( Fig.4C lane 3) , a 60 kDa protein was obtained as expected [16] . 164
Insect bioassay 165
To evaluate the toxicity of the hybrid protein, spore/crystal mix of the recombinant Bt strain 166 was tested for insecticidal activity on larvae of 15-day stage A.corpulenta, 5-day stage H.parallela, 167 and 5-day stage H.oblita. At a concentration of 1.0×10
8 CFU g -1 soil the parent strain HD73 -had 168 no insecticidal activity against any of the three bioassayed insects. The strain expressing the 169 hybrid was shown to be toxic to A.corpulenta larvae (Fig.5) but not to H.parallela or H.oblita. 170
Discussion 171
In recent years many research projects have focused on cloning desired genes from complex 172 DNA samples (metagenomic or pooled DNA) [5, 6, [17] [18] [19] . In such samples the distribution of 173 gene homologues can be unequal and it can be a difficult task to isolate rare forms. Here we have 174 demonstrated the use of redundant exclusion PCR to remove unwanted homologues from a gene 175 pool and thus increase the frequency of rare forms in an amplicon library. 176
Bt is an insect pathogen which during sporulation produces insecticidal proteins that 177 accumulate in the mother cell and form intracellular parasporal crystals [1, 20] . These crystals 178 contain toxins, encoded by cry genes, which are noted for their specific insecticidal activity. Cry 179 proteins have been expressed in crops to control agricultural pests [21, 22] . Due to their 180 commercial value much research has focused on toxin gene discovery and here we have 181 demonstrated the use of an RE-PCR based method that can identify new and rare cry gene 182 homologues from a genomic DNA pool and identified a novel toxin with activity against an 183 economically important pest. The method relies on us being able to identify unique regions in 184 redundant genes and would therefore exclude any otherwise novel genes that happened to share 185 that region. Nonetheless we have demonstrated that the principle works well and alternative RE 186 primers can always be designed in an attempt to overcome this potential limitation. The fact that 187 some cry9Ea profiles could still be detected may represent the fact that this process is not 100% 188 efficient and so there can be some background, which will be particularly noticeable for high 189 abundance genes. Alternatively polymorphisms in the RE primer region could allow amplification 190 of these variants. 191
The toxin that we identified by this method is closely related to other Cry8 toxins, 192 comparison of the active toxin region with all toxins in the nomenclature reveals that the closest 193 match is to Cry8Ab1 with 79% identity. This level of identity is sufficient to consider the toxin 194 novel -studies have shown that just a few amino acid differences in a toxin can not only determine 195 whether or not it is toxic, but also to which insect it has toxicity [23]. This conclusion is supported 196 by our bioassay data: the variant that we have isolated shows activity to A. corpulenta but not to H. 197 oblita or H. parallela. This contrasts with Cry8N which showed activity against the latter insect 198 but not the former two [24] , with Cry8Ga which has activity against the two Holotrichia species 199
but not A. corpulenta [12], Cry8Ab with activity against the two Holotrichia species [25] and with 200
Cry8Fa and another Cry8-like protein that have activity against none or all of these three species 201 respectively [10, 11] . Thus on both sequence and insect specificity levels this newly described 202 toxin has novel attributes which have potential not only for the control of these insects but also in 203 the understanding of specificity determination. It should be noted that our bioassays were 204 conducted on a hybrid toxin in which the C-terminal region was provided by another toxin. While 205 the C-terminal region of the larger Cry toxins is known to be important for toxin 206 expression/packaging [26] and may influence toxicity [27] there is no convincing evidence that it 207 influences specificity and thus we believe that it is reasonable to attribute the observed activity to 208 the newly cloned portion of the toxin. 209
In conclusion, the RE-PCR based approach developed in this paper was able to effectively 210 exclude undesired homologue genes but clone low frequency genes from a complex DNA sample. 211
It is particularly applicable to families of homologous genes where there are known areas with 212 variation that can be used for the design of the RE primers, the method should be suitable for other 213 samples such as metagenomic DNA. 214
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